DOCSLIB.ORG

Acute Myocardial Infarction Due to Coronary Embolism in Atrial Fibrillation: Case Presentation and Systematic Review

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acute Myocardial Infarction Due to Coronary Embolism in Atrial Fibrillation: Case Presentation and Systematic Review www.medigraphic.org.mx Revista Mexicana de Cardiología C C B R Vol. 27 No. 4 October-December 2016 Acute myocardial infarction due to coronary embolism in atrial fibrillation: case presentation and systematic review Infarto agudo de miocardio debido a embolia coronaria en fibrilación auricular: presentación de caso y revisión sistemática Juan Carlos Díaz,* Danilo Weir,** William Uribe,*** Julián Aristizábal,**** Jorge Velásquez,**** Jorge Marin,**** Mauricio Duque***** Key words: Acute myocardial infarction, atrial ABSTRACT RESUMEN fi brillation, coagulation, coronary Atrial fi brillation is the most common sustained arrhyth- La fi brilación auricular es la arritmia sostenida más embolism. mia in the general population, responsible for signifi cant común en la población general, responsable de una gran morbidity and mortality due to an increased risk of morbilidad y mortalidad debido a un mayor riesgo de Palabras clave: systemic embolism. The anatomic and hemodynamic embolia sistémica. Las características hemodinámicas y Infarto agudo characteristics of the cardiovascular system direct most anatómicas del sistema cardiovascular conducen directa- de miocardio, emboli towards the central nervous system or the periph- mente la mayoría de los émbolos hacia el sistema nervioso fi brilación auricular, eral circulation, being coronary embolism an uncommon central o a la circulación periférica, siendo la embolia coagulación, embolia event. This has led to a paucity in the available medical coronaria infrecuente. Esto ha llevado a una escasez en coronaria. literature regarding the importance of atrial fi brillation as la literatura médica sobre la importancia de la fi brilación a cause of acute myocardial infarction and the treatment auricular como causa de infarto agudo de miocardio y * Cardiology and these patients should be off ered, with most of the evidence del tratamiento que debe ser ofrecido a estos pacientes, Electrophysiology. CES arising from case reports and small case series. A case con la mayoría de las pruebas derivadas de informes Cardiología. Clínica of acute myocardial infarction associated with coronary de casos y series de casos pequeñas. Un caso de infarto CES, Medellín. ** Medical Student. embolism in a patient with new onset atrial fi brillation agudo de miocardio asociado con embolia coronaria en Fundación Universitaria who was successfully treated with thrombus aspiration is un paciente con fi brilación auricular de nueva aparición San Martin, Sabaneta. presented, followed by a systematic review of the topic. que fue tratada exitosamente con tromboaspiración es pre- *** Cardiology and The objective of this review is to establish the clinical sentado, seguido de una revisión sistemática del tema. El Electophysiology, characteristics of patients with coronary embolism due to objetivo de esta revisión es determinar las características CES Cardiología. atrial fi brillation and determine the best treatment options clínicas de los pacientes con embolia coronaria debido a Electrophysiology chief based on the available evidence. fi brilación auricular y determinar las mejores opciones de CES Cardiología and tratamiento basadas en la evidencia disponible. Centros Especializados de San Vicente Fundación, Medellín and Rionegro. **** Cardiology and Electrophysiology, CES INTRODUCTION stroke, being responsible for about 1 of every Cardiología. www.medigraphic.org.mx5 ischemic strokes.1-4 Management is based ***** Cardiology and trial fibrillation (AF) is the most common on controlling underlying diseases which Electrophysiology, CES Cardiología. Cardiology Asustained arrhythmia worldwide, being can trigger or perpetuate the arrhythmia chief, CES Cardiología. the main reason for arrhythmia related hos- and defining if the patient is suitable for a pitalization; AF is also associated with a sig- rhythm vs rate control strategy; whichever Received: 1 01/06/2016 nificant increase in mortality. Furthermore, it the strategy chosen evaluation and treatment 1,2 Accepted: is an important cause of cerebral embolism, of embolic risk is warranted. Most emboli 04/11/2016 with five-fold increase in the risk of ischemic are directed towards the cerebral circula- Rev Mex Cardiol 2016; 27 (4): 171-180 www.medigraphic.com/revmexcardiol 172 Díaz JC et al. Acute myocardial infarction due to coronary embolism in atrial fi brillation tion, with less than 11% of embolic events CASE PRESENTATION directed towards systemic circulation.5 The incidence of acute myocardial infarction A 52-year-old man with history of arterial hy- (AMI) as a consequence of AF is unknown,6 pertension (CHA2DS2VASC: 1) was admitted with scarce information available in medi- in June 2015 for palpitations and nausea; his cal literature. Nevertheless, AMI caused by initial ECG in the emergency room reveal- coronary embolism in AF is known to be an ing atrial fibrillation. He described previous infrequent condition (considering the num- episodes of short lasting palpitations, without ber of patients with arrhythmia); a recently previous documentation of AF (first detected published study using the AVERROES, RELY, AF). After initial evaluation, he refered chest ACTIVE A & ACTIVE W database (including pain oppression without ECG changes sug- more than 37,000 patients with an average gesting acute ischemia (Figure 1) but because follow up of 2.4 years, equivalent to 91,746 of an elevated troponin I result (0,595 ng/mL; patient-years) found no episodes of AMI as- reference value: 0,012-0,024 ng/mL) he was sociated to AF-related embolism.5 This low diagnosed with an acute myocardial infarction incidence has led to underepresentation of without ST elevation (NSTEMI). Anticoagulant this association in medical literature; risk (enoxaparine 1 mg/kg each 12 hours) and factors, affected patient’s characteristics anti-platelet aggregation (load of acetylsalicylic and appropriate management are currently acid 300 mg and clopidogrel 300 mg both PO) unknown. A case of AF-related coronary em- were administered and the patient underwent bolism is presented, followed by a systematic coronary angiography. During the procedure, review of the available medical literature to a fresh thrombus in the proximal portion of the summarize the best evidence available. The anterior descendent artery (ADA) with total oc- primary objective is to identify the general clusion of distal circulation was found (Figure 2), characteristics of patients who suffer an AMI without significant atherosclerosis. Mechanical by coronary embolism associated with AF. thrombectomy with aspiration of a red throm- The secondary objective is to define the most bus was performed out, restoring blood flow appropriate treatment strategy for this group through the vessel with a residual oclussion at of patients. the distal portion of the ADA. Subsequent at- www.medigraphic.org.mx Figure 1. 12 lead ECG upon arrival at the emergency room. Atrial fi brillation (lack of a P wave, with variable RR interval) without acute ischemic changes. Rev Mex Cardiol 2016; 27 (4): 171-180 www.medigraphic.com/revmexcardiol Díaz JC et al. Acute myocardial infarction due to coronary embolism in atrial fi brillation 173 tempts during the same procedure completely boembolus» OR «coronary artery embolization») restored normal blood flow. AND atrial fibrillation; the search was limited to A transthoracic echocardiogram performed publications written in English and/or Spanish. after coronary angiography showed a normal Additionally, a search in SciELO and LILACS ejection fraction (60%) without any contractility was performed using the English terms and their disorders; a transesophageal echocardiogram Spanish translation («embolismo coronario» OR performed the next day excluded left atrial «embolismo de arteria coronaria» OR «trombo- trhombus and pharmacologic cardioversion embolia coronaria») AND fibrilación auricular. was undertaken using an intravenous amioda- Publications were included if coronary embo- rone infusion. The patient was discharged with lism related to AF was demonstrated by coro- anti-platelet therapy (acetylsalycilic acid 100 nary angiography; publications what included mg PO/24 h, clopidogrel 75 mg PO/24 h), oral patients with prosthetic valves or alternative anticoagulation with warfarin and anthiarrhyth- sources of emboli (ateromatosis with suspect mic treatment (propafenone 150 mg PO/12 of ateroemboli, infective endocarditis) were h and metoprolol succinate 50 mg PO/24h). excluded. Additionally, bibliographic references One month after the index event, pulmonary of the included publications were reviewed, vein ablation was performed to decrease the aiming to identify studies which had not been risk of arrhythmia recurrence. After a six month included during the initial search. The PubMed follow up, no new episodes of AF have been search yielded 32 results, out of which 19 were documented during Holter monitoring, and the initially excluded due to an alternative source of patient has had no angina episodes. embolism because they were unrelated with the study question (coronary embolism associated ATRIAL FIBRILLATION to AF without prosthetic valves or another em- RELATED CORONARY EMBOLISM: boli causes); another publication was excluded SYSTEMATIC REVIEW because it was a letter to editor. The EMBASE search yielded 53 results in total, out of which Methods: A systematic search of databases 30 were excluded due to an alternative source (Pubmed, EMBASE and Cochrane) was made of embolism; 7 were unrelated to the study in November 2015 using the terms
Load more

Recommended publications
  • Non Commercial Use Only
    Cardiogenetics 2017; volume 7:6304 Sudden death in a young patient with atrial fibrillation Case Report Correspondence: María Angeles Espinosa Castro, Inherited Cardiovascular Disease A 22-year-old man suffered a sudden Program, Cardiology Department, Gregorio María Tamargo, cardiac arrest without previous symptoms Marañón Hospital, Dr. Esquerdo, 46, 28007, María Ángeles Espinosa, while he was at rest, waiting for a subway Madrid, Spain. Víctor Gómez-Carrillo, Miriam Juárez, train. Cardiopulmonary resuscitation was Tel.: +34.91.586.82.90. immediately started using an Automated E-mail: [email protected] Francisco Fernández-Avilés, External Defibrillation that identified the Raquel Yotti Key words: KCNQ1; mutation; channelopa- presence of ventricular fibrillation and thy; sudden cardiac death; atrial fibrillation. Inherited Cardiovascular Disease delivered a shock. Return of spontaneous Program, Cardiology Department, circulation was achieved after three Contributions: MT, acquisition and interpreta- Gregorio Marañón Hospital, Madrid, attempts, being atrial fibrillation (AF) the tion of data for the work, ensuring that ques- Spain patient’s rhythm at this point (Figure 1). tions related to the accuracy or integrity of any He was admitted to our Cardiovascular part of the work is appropriately investigated Intensive Care Unit and therapeutic and resolved; MAE, conception of the work, hypothermia was performed over a period critical revision of the intellectual content, final approval of the version to be published, Abstract of 24 h. After completing hypothermia, ensuring that questions related to the accuracy rewarming, and another 24 h of controlled of any part of the work is appropriately inves- Sudden cardiac death (SCD) in young normothermia the patient awakened with no tigated and resolved; VG-C, acquisition and patients without structural heart disease is residual neurologic damage.
    [Show full text]
  • Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease
    Europace (2017) 0, 1–21 EHRA CONSENSUS DOCUMENT doi:10.1093/europace/eux240 Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardıaca y Electrofisiologıa (SOLEACE) Gregory Y. H. Lip1*, Jean Philippe Collet2, Raffaele de Caterina3, Laurent Fauchier4, Deirdre A. Lane5, Torben B. Larsen6, Francisco Marin7, Joao Morais8, Calambur Narasimhan9, Brian Olshansky10, Luc Pierard11, Tatjana Potpara12, Nizal Sarrafzadegan13, Karen Sliwa14, Gonzalo Varela15, Gemma Vilahur16, Thomas Weiss17, Giuseppe Boriani18 and Bianca Rocca19 Document Reviewers: Bulent Gorenek20 (Reviewer Coordinator), Irina Savelieva21, Christian Sticherling22, Gulmira Kudaiberdieva23, Tze-Fan Chao24, Francesco Violi25, Mohan Nair26, Leandro Zimerman27, Jonathan Piccini28, Robert Storey29, Sigrun Halvorsen30, Diana Gorog31, Andrea Rubboli32, Ashley Chin33 and Robert Scott-Millar34 * Corresponding author. Tel/fax: þ44 121 5075503. E-mail address: [email protected] Published on behalf of the European Society of Cardiology. All rights reserved. VC The Author 2017. For permissions, please email: [email protected]. 2 G.Y.H. Lip 1Institute of Cardiovascular Sciences, University of Birmingham and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (Chair, representing EHRA); 2Sorbonne Universite´ Paris 6, ACTION Study Group, Institut De Cardiologie, Groupe Hoˆpital Pitie´-Salpetrie`re (APHP), INSERM UMRS 1166, Paris, France; 3Institute of Cardiology, ‘G.
    [Show full text]
  • Cardiovascular Disease and Rehab
    EXERCISE AND CARDIOVASCULAR ! CARDIOVASCULAR DISEASE Exercise plays a significant role in the prevention and rehabilitation of cardiovascular diseases. High blood pressure, high cholesterol, diabetes and obesity can all be positively affected by an appropriate and regular exercise program which in turn benefits cardiovascular health. Cardiovascular disease can come in many forms including: Acute coronary syndromes (coronary artery disease), myocardial ischemia, myocardial infarction (MI), Peripheral artery disease and more. Exercise can improve cardiovascular endurance and can improve overall quality of life. If you have had a cardiac event and are ready to start an appropriate exercise plan, Cardiac Rehabilitation may be the best option for you. Please call 317-745-3580 (Danville Hospital campus), 317-718-2454 (YMCA Avon campus) or 317-456-9058 (Brownsburg Hospital campus) for more information. SAFETY PRECAUTIONS • Ask your healthcare team which activities are most appropriate for you. • If prescribed nitroglycerine, always carry it with you especially during exercise and take all other medications as prescribed. • Start slow and gradually progress. If active before event, fitness levels may be significantly lower – listen to your body. A longer cool down may reduce complications. • Stop exercising immediately if you experience chest pain, fatigue, or labored breathing. • Avoid exercising in extreme weather conditions. • Drink plenty of water before, during, and after exercise. • Wear a medical identification bracelet, necklace, or ID tag in case of emergency. • Wear proper fitting shoes and socks, and check feet after exercise. STANDARD GUIDELINES F – 3-5 days a week. Include low weight resistance training 2 days/week I – 40-80% of exercise capacity using the heart rate reserve (HRR) (220-age=HRmax; HRmax-HRrest = HRR) T – 20-60mins/session, may start with sessions of 5-15 mins if necessary T – Large rhythmic muscle group activities that are low impact (walking, swimming, biking) Get wellness tips to keep YOU healthy at HENDRICKS.ORG/SOCIAL..
    [Show full text]
  • Myocardial Infarction (Heart Attack)
    Sacramento Heart & Vascular Medical Associates February 19, 2012 500 University Ave. Sacramento, CA 95825 Page 1 916-830-2000 Fax: 916-830-2001 Patient Information For: Only A Test Myocardial Infarction (Heart Attack) What is a myocardial infarction (MI)? Myocardial infarction (MI) is a heart attack. It happens when blood flow to a part of the heart is suddenly blocked. How does it occur? Myocardial infarction may occur at any time and often occurs without warning. As we grow older, our coronary arteries may become narrowed by the buildup of cholesterol plaque. When the arteries narrow, less blood can go through them, and less oxygen gets to the heart muscle. The process of narrowing is called atherosclerosis. The narrower the artery becomes, the more likely it is that a blood clot may form and block the artery completely, causing a heart attack. Sometimes sudden blockages can occur even in places where the artery was not narrow before. A heart attack may also occur when the heart muscle needs more oxygen than the blood vessels can provide. This might happen, for example, during hard exercise such as shoveling snow, or with a sudden increase in blood pressure. Less commonly, a heart attack can occur due to coronary spasm. Coronary spasm is a sudden and temporary narrowing of a small part of an artery that supplies blood to the heart. It may be caused by smoking or drugs such as cocaine. Risk factors for heart disease include: - cigarette smoking - a family history of heart attack - diabetes - overweight - high blood pressure - high blood cholesterol - low HDL cholesterol (that is, too little "good" cholesterol) - stress - a lifestyle that does not include much physical activity.
    [Show full text]
  • The Management of Acute Coronary Syndromes in Patients Presenting
    CONCISE GUIDANCE Clinical Medicine 2021 Vol 21, No 2: e206–11 The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician Authors: Ramesh NadarajahA and Chris GaleB There have been significant advances in the diagnosis and international decline in mortality rates.2,3 In September 2020, management of non-ST-segment elevation myocardial the European Society of Cardiology (ESC) published updated infarction over recent years, which has been reflected in an Clinical Practice Guidelines for the management of ACS in patients international decline in mortality rates. This article provides an presenting without persistent ST-segment elevation,4 5 years after overview of the 2020 European Society of Cardiology Clinical the last iteration. ABSTRACT Practice Guidelines for the topic, concentrating on areas relevant The guidelines stipulate a number of updated recommendations to the general or emergency physician. The recommendations (supplementary material S1). The strength of a recommendation and underlying evidence basis are analysed in three key and level of evidence used to justify it are weighted and graded areas: diagnosis (the recommendation to use high sensitivity according to predefined scales (Table 1). This focused review troponin and how to apply it), pathways (the recommendation provides learning points derived from the guidelines in areas to facilitate early invasive coronary angiography to improve relevant to general and emergency physicians, including diagnosis outcomes and shorten hospital stays) and treatment (a (recommendation to use high sensitivity troponin), pathways paradigm shift in the use of early intensive platelet inhibition).
    [Show full text]
  • Common Types of Supraventricular Tachycardia: Diagnosis and Management RANDALL A
    Common Types of Supraventricular Tachycardia: Diagnosis and Management RANDALL A. COLUCCI, DO, MPH, Ohio University College of Osteopathic Medicine, Athens, Ohio MITCHELL J. SILVER, DO, McConnell Heart Hospital, Columbus, Ohio JAY SHUBROOK, DO, Ohio University College of Osteopathic Medicine, Athens, Ohio The most common types of supraventricular tachycardia are caused by a reentry phenomenon producing acceler- ated heart rates. Symptoms may include palpitations (including possible pulsations in the neck), chest pain, fatigue, lightheadedness or dizziness, and dyspnea. It is unusual for supraventricular tachycardia to be caused by structurally abnormal hearts. Diagnosis is often delayed because of the misdiagnosis of anxiety or panic disorder. Patient history is important in uncovering the diagnosis, whereas the physical examination may or may not be helpful. A Holter moni- tor or an event recorder is usually needed to capture the arrhythmia and confirm a diagnosis. Treatment consists of short-term or as-needed pharmacotherapy using calcium channel or beta blockers when vagal maneuvers fail to halt or slow the rhythm. In those who require long-term pharmacotherapy, atrioventricular nodal blocking agents or class Ic or III antiarrhythmics can be used; however, these agents should generally be managed by a cardiologist. Catheter ablation is an option in patients with persistent or recurrent supraventricular tachycardia who are unable to tolerate long-term pharmacologic treatment. If Wolff-Parkinson-White syndrome is present, expedient referral
    [Show full text]
  • Treatment of Acute Coronary Syndrome
    Acute Coronary Syndrome: Current Treatment TIMOTHY L. SWITAJ, MD, U.S. Army Medical Department Center and School, Fort Sam Houston, Texas SCOTT R. CHRISTENSEN, MD, Martin Army Community Hospital Family Medicine Residency Program, Fort Benning, Georgia DEAN M. BREWER, DO, Guthrie Ambulatory Health Care Clinic, Fort Drum, New York Acute coronary syndrome continues to be a significant cause of morbidity and mortality in the United States. Family physicians need to identify and mitigate risk factors early, as well as recognize and respond to acute coronary syn- drome events quickly in any clinical setting. Diagnosis can be made based on patient history, symptoms, electrocardi- ography findings, and cardiac biomarkers, which delineate between ST elevation myocardial infarction and non–ST elevation acute coronary syndrome. Rapid reperfusion with primary percutaneous coronary intervention is the goal with either clinical presentation. Coupled with appropriate medical management, percutaneous coronary interven- tion can improve short- and long-term outcomes following myocardial infarction. If percutaneous coronary interven- tion cannot be performed rapidly, patients with ST elevation myocardial infarction can be treated with fibrinolytic therapy. Fibrinolysis is not recommended in patients with non–ST elevation acute coronary syndrome; therefore, these patients should be treated with medical management if they are at low risk of coronary events or if percutaneous coronary intervention cannot be performed. Post–myocardial infarction care should
    [Show full text]
  • What Is Atrial Fibrillation?
    ANSWERS Cardiovascular Conditions by heart What Is Atrial Fibrillation? Normally, your heart contracts and relaxes to a regular beat. Certain cells in your heart, called the sinus node, make electrical The illustrations above show normal conduction and contraction. signals that cause the heart to contract and pump blood. These electrical signals can be recorded using an electrocardiogram, or Sinus node ECG. Your doctor can read your ECG to find out if the electrical signals are normal. Left atrium In atrial fibrillation, or AFib, the heart’s Right atrium two small upper chambers (atria) beat irregularly and too fast, quivering instead of contracting properly. With atrial fibrillation, random electrical activity During AFib, some blood may not be interrupts the normal pumped efficiently from the atria into the conduction rhythm. ventricles. Blood that’s left behind can pool This prevents the atria from in the atria and form blood clots. properly contracting. How do I know I have atrial fibrillation? The risk of stroke is about five times higher in people with AFib. This is because blood can pool in the atria and blood Some people with AFib don’t have symptoms. Some of the clots can form. symptoms are: • Fast, irregular heartbeat What can be done to correct AFib? • Heart palpitations (rapid “flopping” or “fluttering” feeling in the chest) Treatment options may include one or more of the following: • Feeling lightheaded or faint • Medication to help slow your heart rate, such as beta • Chest pain or pressure blockers, certain calcium channel blockers or digoxin • Shortness of breath, especially when lying down • Medication to restore normal heart rhythm, such as • Tiring more easily (fatigue) beta blockers or antiarrhythmics • Procedures to stop or control the electrical impulses Can AFib lead to other problems? causing the AFib, such as electrical cardioversion or catheter ablation You can live with and manage AFib.
    [Show full text]
  • Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms
    AORTIC STENOSIS Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms Kerry A. Esquitin, MD, Omar K. Khalique, MD, Qi Liu, MD, Susheel K. Kodali, MD, Leo Marcoff, MD, Tamim M. Nazif, MD, Isaac George, MD, Torsten P. Vahl, MD, Martin B. Leon, MD, and Rebecca T. Hahn, MD, New York, New York; and Morristown, New Jersey Introduction: In irregular heart rhythms, echocardiographic calculation of aortic effective orifice area (EOA) re- quires averaging measurements from multiple cardiac cycles. Whether a single cycle length method can be used to calculate aortic EOA in aortic stenosis with nonsinus rhythms is not known. Methods: Transthoracic echocardiograms of 100 patients with aortic stenosis and either atrial fibrillation (AF) or frequent ectopy (FE) were retrospectively reviewed. The aortic valve velocity time integral (VTIAV) and the left ven- tricular outflow tract VTI (VTILVOT) were measured by two methods: the standard method (averaging multiple beats) and the single cycle length method. The latter matches the R-R intervals for VTIAV and VTILVOT.Stroke volume, EOA, and Doppler velocity index were calculated by both methods in all patients. The single cycle length method was used for short and long R-R cycles in AF and for postectopic beats (long R-R cycles) in FE. Results: In AF, long R-R cycles resulted in larger stroke volumes (73 6 21 vs 63 6 18 mL; P # .0001) but no difference in EOA (0.84 6 0.27 vs 0.82 6 0.27 cm2; P = .11), whereas short R-R cycles resulted in smaller stroke volumes (55 6 18 vs 63 6 18 mL, P # .0001) but a larger EOA (0.86 6 0.28 vs 0.82 6 0.27 cm2; P = .01).
    [Show full text]
  • The Pattern of Cardiac Arrhythmias in Acute ST Elevated Myocardial
    University Heart Journal Vol. 16, No. 1, January 2020 The Pattern of Cardiac Arrhythmias in Acute ST Elevated 16 Myocardial Infarction and their in-hospital Outcome MOHAMMAD KHURSHADUL ALAM, MANZOOR MAHMOOD, DIPAL KRISHNA ADHIKARY, FAKHRUL ISLAM 01 - V KHALED, MSI TIPU CHOWDHURY, AMANAT HASAN, SAMI NAZRUL ISLAM, MD. ASHRAF UDDIN SULTAN, SAJAL KRISHNA BANERJEE Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka,Bangladesh. ol. 16, No. 1, Address of Correspondence: Dr. Muhammad Khurshadul Alam, Department of Cardiology,Bangabandhu Sheikh MujibMedical University,Dhaka,Bangladesh. Email: [email protected] Abstract: Background: Acute myocardial infarction (AMI) is a major cause of death worldwide with arrhythmia being JANUAR the most common determinant in the post-infarction period. Identification and management of arrhythmias at an early period of acute MI has both short term and long term significance.Objective: The aim of the study is to evaluate the pattern of arrhythmias in acute STEMI in the first 48 hours of hospitalization and their in- hospital outcome. Methods: A total of 50 patients with acute STEMI were included in the study after considering Y 2020 BSMMU H.J. the inclusion and exclusion criteria. The patients were observed for the first 48 hours of hospitalization for detection of arrhythmia with baseline ECG at admission and continuous cardiac monitoring in the CCU. The pattern of the arrhythmias during this period & their in-hospital outcome were recorded in predesigned structured data collection sheet.Result: The mean age was 53.38 ± 10.22 years ranging from 29 to 70 years. Most of the patients were male 42(84%).
    [Show full text]
  • Premature Ventricular Contractions Ralph Augostini, MD FACC FHRS
    Premature Ventricular Contractions Ralph Augostini, MD FACC FHRS Orlando, Florida – October 7-9, 2011 Premature Ventricular Contractions: ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death J Am Coll Cardiol, 2006; 48:247-346. Background PVCs are ectopic impulses originating from an area distal to the His Purkinje system Most common ventricular arrhythmia Significance of PVCs is interpreted in the context of the underlying cardiac condition Ventricular ectopy leading to ventricular tachycardia (VT), which, in turn, can degenerate into ventricular fibrillation, is one of the common mechanisms for sudden cardiac death The treatment paradigm in the 1970s and 1980s was to eliminate PVCs in patients after myocardial infarction (MI). CAST and other studies demonstrated that eliminating PVCs with available anti-arrhythmic drugs increases the risk of death to patients without providing any measurable benefit Pathophysiology Three common mechanisms exist for PVCs, (1) automaticity, (2) reentry, and (3) triggered activity: Automaticity: The development of a new site of depolarization in non-nodal ventricular tissue. Reentry circuit: Reentry typically occurs when slow- conducting tissue (eg, post-infarction myocardium) is present adjacent to normal tissue. Triggered activity: Afterdepolarization can occur either during (early) or after (late) completion of repolarization. Early afterdepolarizations commonly are responsible for bradycardia associated PVCs, but also with ischemia and electrolyte disturbance. Triggered Fogoros: Electrophysiologic Testing. 3rd ed. Blackwell Scientific 1999; 158. Epidemiology Frequency The Framingham heart study (with 1-h ambulatory ECG) 1 or more PVCs per hour was 33% in men without coronary artery disease (CAD) and 32% in women without CAD Among patients with CAD, the prevalence rate of 1 or more PVCs was 58% in men and 49% in women.
    [Show full text]
  • Cardiac Arrhythmias in Acute Coronary Syndromes: Position Paper from the Joint EHRA, ACCA, and EAPCI Task Force
    FOCUS ARTICLE Euro Intervention 2014;10-online publish-ahead-of-print August 2014 Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force Bulent Gorenek*† (Chairperson, Turkey), Carina Blomström Lundqvist† (Sweden), Josep Brugada Terradellas† (Spain), A. John Camm† (UK), Gerhard Hindricks† (Germany), Kurt Huber‡ (Austria), Paulus Kirchhof† (UK), Karl-Heinz Kuck† (Germany), Gulmira Kudaiberdieva† (Turkey), Tina Lin† (Germany), Antonio Raviele† (Italy), Massimo Santini† (Italy), Roland Richard Tilz† (Germany), Marco Valgimigli¶ (The Netherlands), Marc A. Vos† (The Netherlands), Christian Vrints‡ (Belgium), and Uwe Zeymer‡ (Germany) Document Reviewers: Gregory Y.H. Lip (Review Coordinator) (UK), Tatjania Potpara (Serbia), Laurent Fauchier (France), Christian Sticherling (Switzerland), Marco Roffi (Switzerland), Petr Widimsky (Czech Republic), Julinda Mehilli (Germany), Maddalena Lettino (Italy), Francois Schiele (France), Peter Sinnaeve (Belgium), Giueseppe Boriani (Italy), Deirdre Lane (UK), and Irene Savelieva (on behalf of EP-Europace, UK) Introduction treatment. Atrial fibrillation (AF) may also warrant urgent treat- It is known that myocardial ischaemia and infarction leads to severe ment when a fast ventricular rate is associated with hemodynamic metabolic and electrophysiological changes that induce silent or deterioration. The management of other arrhythmias is also based symptomatic life-threatening arrhythmias. Sudden cardiac death is largely on symptoms rather than to avert
    [Show full text]